Igal Kushnir

668 total citations
34 papers, 410 citations indexed

About

Igal Kushnir is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Igal Kushnir has authored 34 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 8 papers in Surgery. Recurrent topics in Igal Kushnir's work include Prostate Cancer Treatment and Research (6 papers), Phonocardiography and Auscultation Techniques (4 papers) and Renal cell carcinoma treatment (3 papers). Igal Kushnir is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Phonocardiography and Auscultation Techniques (4 papers) and Renal cell carcinoma treatment (3 papers). Igal Kushnir collaborates with scholars based in Israel, Canada and United States. Igal Kushnir's co-authors include Ido Wolf, R. Phillip Dellinger, Joseph E. Parrillo, Marcello Rossi, Venkata Bandi, Kalpalatha K. Guntupalli, Philip Alapat, Issahar Ben-Dov, Tzahala Tzuk-Shina and Thomas E Serena and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nutrients.

In The Last Decade

Igal Kushnir

34 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igal Kushnir Israel 11 231 115 51 41 36 34 410
Izumi Saito Japan 10 96 0.4× 98 0.9× 37 0.7× 69 1.7× 14 0.4× 26 324
Shaoyong Wu China 8 100 0.4× 43 0.4× 49 1.0× 74 1.8× 19 0.5× 16 338
Rida Salman United States 8 76 0.3× 18 0.2× 10 0.2× 58 1.4× 9 0.3× 41 305
Jang Kyu Choi South Korea 10 89 0.4× 84 0.7× 7 0.1× 130 3.2× 66 1.8× 18 382
Iain Au‐Yong United Kingdom 9 62 0.3× 68 0.6× 14 0.3× 102 2.5× 71 2.0× 21 463
Ansar Mahmood United Kingdom 11 131 0.6× 25 0.2× 87 1.7× 164 4.0× 125 3.5× 30 416
Luca Cecchini Italy 10 212 0.9× 53 0.5× 59 1.2× 45 1.1× 17 0.5× 15 458
Orçun Altunören Türkiye 10 42 0.2× 33 0.3× 6 0.1× 75 1.8× 78 2.2× 48 343
Emre Kaçar Türkiye 10 54 0.2× 28 0.2× 29 0.6× 105 2.6× 25 0.7× 44 297
James J. O’Brien United States 12 196 0.8× 18 0.2× 26 0.5× 102 2.5× 46 1.3× 26 423

Countries citing papers authored by Igal Kushnir

Since Specialization
Citations

This map shows the geographic impact of Igal Kushnir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igal Kushnir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igal Kushnir more than expected).

Fields of papers citing papers by Igal Kushnir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igal Kushnir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igal Kushnir. The network helps show where Igal Kushnir may publish in the future.

Co-authorship network of co-authors of Igal Kushnir

This figure shows the co-authorship network connecting the top 25 collaborators of Igal Kushnir. A scholar is included among the top collaborators of Igal Kushnir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igal Kushnir. Igal Kushnir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keizman, Daniel, Moshe Frenkel, Avivit Peer, et al.. (2023). Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study. Nutrients. 15(16). 3533–3533. 6 indexed citations
2.
Keizman, Daniel, Moshe Frenkel, Avivit Peer, et al.. (2023). P-MCP treatment in non-metastatic biochemically relapsed prostate cancer (BRPC-M0): Final long-term results of a prospective phase II study.. Journal of Clinical Oncology. 41(6_suppl). 162–162. 1 indexed citations
3.
Kushnir, Igal, et al.. (2023). Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome. Physiological Research. 72(S4). S423–S427. 2 indexed citations
4.
Rouvinov, Keren, Avivit Peer, Michal Sarfaty, et al.. (2023). Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis. Frontiers in Oncology. 13. 1151701–1151701. 3 indexed citations
5.
Kushnir, Igal, Naveen S. Basappa, Sunita Ghosh, et al.. (2021). Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System. Clinical Genitourinary Cancer. 19(6). 521–530. 12 indexed citations
6.
Kushnir, Igal, Ranjeeta Mallick, Michael Ong, et al.. (2020). Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer. Cancer Chemotherapy and Pharmacology. 85(5). 863–868. 4 indexed citations
7.
Clemons, Mark, Michael Ong, Carol Stober, et al.. (2020). A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer. European Journal of Cancer. 142. 132–140. 37 indexed citations
8.
Kushnir, Igal, Ranjeeta Mallick, Raymond H. Kim, et al.. (2019). Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database. Clinical Oncology. 32(1). e10–e15. 5 indexed citations
9.
Kushnir, Igal, Michael Ong, Christina Canil, et al.. (2019). The timing of docetaxel initiation in metastatic castrate-sensitive prostate cancer and the rate of chemotherapy-induced toxicity. Medical Oncology. 36(2). 18–18. 6 indexed citations
10.
Kushnir, Igal, et al.. (2018). The timing of docetaxel initiation in metastatic castrate sensitive prostate cancer and the rate of chemotherapy induced toxicity.. Journal of Clinical Oncology. 36(15_suppl). e17005–e17005. 2 indexed citations
11.
Kushnir, Igal, et al.. (2016). Efficacy and Safety of a Novel Autologous Wound Matrix in the Management of Complicated, Chronic Wounds: A Pilot Study.. PubMed. 28(9). 317–327. 10 indexed citations
12.
Kushnir, Igal & Ido Wolf. (2016). Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion. Cardiology. 136(1). 49–51. 62 indexed citations
13.
Kushnir, Igal, et al.. (2014). Is it important to maintain high-dose intensity chemotherapy in the treatment of adults with osteosarcoma?. Medical Oncology. 31(5). 936–936. 4 indexed citations
14.
Kushnir, Igal & Ofer Merimsky. (2012). The evolution in melanoma treatment as a reflection of precision-oriented medicine. Oncology Letters. 5(2). 424–426. 6 indexed citations
15.
Kushnir, Igal, et al.. (2011). Estimation of left ventricular function using a novel acoustic‐based device. European Journal of Clinical Investigation. 42(4). 402–410. 4 indexed citations
16.
Guntupalli, Kalpalatha K., Philip Alapat, Venkata Bandi, & Igal Kushnir. (2008). Validation of Automatic Wheeze Detection in Patients with Obstructed Airways and in Healthy Subjects. Journal of Asthma. 45(10). 903–907. 31 indexed citations
17.
Kushnir, Igal, et al.. (2007). Breath Sound Distribution Images of Patients With Pneumonia and Pleural Effusion. Respiratory Care. 52(12). 1753–1760. 36 indexed citations
18.
Dellinger, R. Phillip, et al.. (2007). Dynamic Visualization of Lung Sounds with a Vibration Response Device: A Case Series. Respiration. 75(1). 60–72. 76 indexed citations
19.
Nesher, Nahum, Tamir Wolf, Gideon Uretzky, et al.. (2001). A novel thermoregulatory system maintains perioperative normothermia in children undergoing elective surgery. Pediatric Anesthesia. 11(5). 555–560. 12 indexed citations
20.
Nesher, Nahum, Tamir Wolf, Igal Kushnir, et al.. (2001). Novel thermoregulation system for enhancing cardiac function and hemodynamics during coronary artery bypass graft surgery. The Annals of Thoracic Surgery. 72(3). S1069–S1076. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026